Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-03

Clinical Trial Update: 2-octyl Cyanoacrylate for Closure of Urethrocutaneous Fistula. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating 2-octyl cyanoacrylate for closure of urethrocutaneous fistula has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2-Octyl cyanoacrylate (2-Octyl cyanoacrylate)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Urethrocutaneous Fistulas | Phase 3 | Status: COMPLETED